#9448. Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program

September 2026publication date
Proposal available till 10-05-2025
4 total number of authors per manuscript0 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Psychiatric Mental Health;
Clinical Psychology;
Psychiatry and Mental Health;
Medicine (miscellaneous);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
2510 $1340 $1170 $1000 $
Contract №9448.1 Contract №9448.2 Contract №9448.3 Contract №9448.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
Aims: To evaluate associations between new types of buprenorphine waivers (nurse practitioner and physician assistant [NP/PA]; 275-patient limit [MD/DO-275]) and both buprenorphine prescribing and health outcomes. Methods: Using comprehensive county-level data from California 20XX–20XX, we modeled quarterly associations between numbers of NP/PA and MD/DO-275 waivers and rates of buprenorphine prescribing, opioid-related deaths, emergency department (ED) visits, and hospitalizations among all counties and separately among metropolitan and nonmetropolitan counties using Poisson regression models with county and quarter fixed effects and adjusting for time-varying covariates.
Keywords:
Buprenorphine; Buprenorphine waiver program; Opioid agonist treatment; Opioid use disorder

Contacts :
0